138 related articles for article (PubMed ID: 17489582)
21. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
[TBL] [Abstract][Full Text] [Related]
22. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
23. Identification of 10-dehydrooxyglycyuralin E as a selective human estrogen receptor alpha partial agonist.
Saito N; Kawase K; Yamashita N; Tang Y; Wang Y; Wang J; Liu Y; Li N; Li W; Cheng MS; Koike K; Kanno Y; Nemoto K
Bioorg Chem; 2019 Jul; 88():102977. PubMed ID: 31100617
[TBL] [Abstract][Full Text] [Related]
24. Efficient access to 2-aryl-3-substituted benzo[b]thiophenes.
David E; Perrin J; Pellet-Rostaing S; Fournier dit Chabert J; Lemaire M
J Org Chem; 2005 Apr; 70(9):3569-73. PubMed ID: 15844992
[TBL] [Abstract][Full Text] [Related]
25. Thiophene-core estrogen receptor ligands having superagonist activity.
Min J; Wang P; Srinivasan S; Nwachukwu JC; Guo P; Huang M; Carlson KE; Katzenellenbogen JA; Nettles KW; Zhou HB
J Med Chem; 2013 Apr; 56(8):3346-66. PubMed ID: 23586645
[TBL] [Abstract][Full Text] [Related]
26. Arzoxifene: the development and clinical outcome of an ideal SERM.
Munster PN
Expert Opin Investig Drugs; 2006 Mar; 15(3):317-26. PubMed ID: 16503767
[TBL] [Abstract][Full Text] [Related]
27. Aliphatic substitution of o-carboranyl phenols enhances estrogen receptor beta selectivity.
Ohta K; Ogawa T; Kaise A; Oda A; Endo Y
Chem Pharm Bull (Tokyo); 2014; 62(4):386-91. PubMed ID: 24695349
[TBL] [Abstract][Full Text] [Related]
28. Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.
Liu H; Qin Z; Thatcher GR; Bolton JL
Chem Res Toxicol; 2007 Nov; 20(11):1676-84. PubMed ID: 17630709
[TBL] [Abstract][Full Text] [Related]
29. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.
Chesworth R; Wessel MD; Heyden L; Mangano FM; Zawistoski M; Gegnas L; Galluzzo D; Lefker B; Cameron KO; Tickner J; Lu B; Castleberry TA; Petersen DN; Brault A; Perry P; Ng O; Owen TA; Pan L; Ke HZ; Brown TA; Thompson DD; DaSilva-Jardine P
Bioorg Med Chem Lett; 2005 Dec; 15(24):5562-6. PubMed ID: 16219463
[TBL] [Abstract][Full Text] [Related]
31. Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists.
Chesworth R; Zawistoski MP; Lefker BA; Cameron KO; Day RF; Mangano FM; Rosati RL; Colella S; Petersen DN; Brault A; Lu B; Pan LC; Perry P; Ng O; Castleberry TA; Owen TA; Brown TA; Thompson DD; DaSilva-Jardine P
Bioorg Med Chem Lett; 2004 Jun; 14(11):2729-33. PubMed ID: 15125923
[TBL] [Abstract][Full Text] [Related]
32. An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.
VandeVrede L; Abdelhamid R; Qin Z; Choi J; Piyankarage S; Luo J; Larson J; Bennett BM; Thatcher GR
PLoS One; 2013; 8(8):e70740. PubMed ID: 23976955
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
[TBL] [Abstract][Full Text] [Related]
34. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats.
Walf AA; Frye CA
Neuropsychopharmacology; 2005 Sep; 30(9):1598-609. PubMed ID: 15798780
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
Kim S; Wu J; Chen HY; Birzin ET; Chan W; Yang YT; Colwell L; Li S; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jun; 14(11):2741-5. PubMed ID: 15125925
[TBL] [Abstract][Full Text] [Related]
37. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
[TBL] [Abstract][Full Text] [Related]
38. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures.
Benvenuti S; Luciani P; Vannelli GB; Gelmini S; Franceschi E; Serio M; Peri A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1775-82. PubMed ID: 15585566
[TBL] [Abstract][Full Text] [Related]
39. Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites.
Yu BL; Mai ZX; Liu XX; Huang ZF
Acta Pharmacol Sin; 2013 Mar; 34(3):373-9. PubMed ID: 23334240
[TBL] [Abstract][Full Text] [Related]
40. Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.
Marrero-Alonso J; Morales A; García Marrero B; Boto A; Marín R; Cury D; Gómez T; Fernández-Pérez L; Lahoz F; Díaz M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):898-910. PubMed ID: 23727370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
